• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斯威士兰零售药店处方药的可获得性、价格和可负担性。

Retail pharmacy prescription medicines' availability, prices and affordability in Eswatini.

机构信息

Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban.

出版信息

Afr J Prim Health Care Fam Med. 2021 Sep 15;13(1):e1-e11. doi: 10.4102/phcfm.v13i1.2986.

DOI:10.4102/phcfm.v13i1.2986
PMID:34636605
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8517741/
Abstract

BACKGROUND

Limited availability of medicines in public facilities and unaffordable prices in the private sector act as barriers to medicines' access. Patients in Eswatini may be forced to buy medicine from the private sector resulting from chronic medicines' shortages in public health facilities. The extent to which they can afford to do so is unknown.

AIM

To determine the availability, price and affordability of medicines in the retail pharmacies in Eswatini, and to compare the results regionally and internationally.

SETTING

Retail pharmacy sector in the four administrative regions of Eswatini.

METHODS

Data on availability, price and affordability to patients for 50 medicines in the originator brand (OB) and the lowest priced generic (LPG) equivalent, were collated using the standardised World Health Organization/Health Action International methodology from 32 retail pharmacies in the four regions of Eswatini. Prices were then compared with selected countries.

RESULTS

The overall mean availability of all medicines in selected retail pharmacies was 38.5%; standard deviation [s.d.] = 20.4% for OBs and 80.9%; s.d. = 19.0% for LPGs. The overall median price ratio (MPR) in the surveyed pharmacies was 18.61 for the OBs and 4.67 for LPGs. Most standard treatments with LPGs cost less than a day's wages whilst for OBs cost more than a day's wages. The differences between Eswatini and South African prices were statistically significant.

CONCLUSION

Drug pricing policies and price monitoring tools are needed for the whole pharmaceutical chain in Eswatini to monitor availability, affordability and accessibility of medicines to the general populace.

摘要

背景

公共设施中药品的供应有限,私营部门的药品价格过高,这成为了药品获取的障碍。由于公共卫生设施长期缺乏药品,斯威士兰的患者可能被迫从私营部门购买药品。但他们能够负担得起的程度尚不清楚。

目的

确定斯威士兰零售药店的药品供应情况、价格和可负担性,并在区域和国际范围内进行比较。

设置

斯威士兰四个行政区的零售药房部门。

方法

采用世界卫生组织/国际健康行动组织的标准化方法,从斯威士兰四个地区的 32 家零售药店收集了 50 种药品的原始品牌(OB)和最便宜的仿制药(LPG)的供应情况、价格和患者可负担性数据。然后将价格与选定国家进行比较。

结果

在选定的零售药店中,所有药品的总体平均供应率为 38.5%;OB 的标准差为 20.4%,LPG 的标准差为 80.9%。调查药店的总体中位数价格比(MPR)为 OB 为 18.61,LPG 为 4.67。大多数使用 LPG 的标准治疗费用低于一天的工资,而 OB 的治疗费用则高于一天的工资。斯威士兰和南非的价格差异具有统计学意义。

结论

斯威士兰需要制定整个医药供应链的药品定价政策和价格监测工具,以监测普通民众的药品供应、可负担性和可及性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46e/8517741/855ee5837721/PHCFM-13-2986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46e/8517741/855ee5837721/PHCFM-13-2986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d46e/8517741/855ee5837721/PHCFM-13-2986-g001.jpg

相似文献

1
Retail pharmacy prescription medicines' availability, prices and affordability in Eswatini.斯威士兰零售药店处方药的可获得性、价格和可负担性。
Afr J Prim Health Care Fam Med. 2021 Sep 15;13(1):e1-e11. doi: 10.4102/phcfm.v13i1.2986.
2
Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.巴基斯坦拉合尔分部基本药物的价格、可及性和可负担性评估:使用世卫组织/卫生技术评估机构方法的横断面调查。
PLoS One. 2019 Apr 25;14(4):e0216122. doi: 10.1371/journal.pone.0216122. eCollection 2019.
3
Availability, prices and affordability of selected essential medicines in Jordan: a national survey.约旦特定基本药物的可及性、价格及可负担性:一项全国性调查
BMC Health Serv Res. 2018 Oct 19;18(1):787. doi: 10.1186/s12913-018-3593-9.
4
A comprehensive survey of cancer medicines prices, availability and affordability in Ghana.加纳癌症药物价格、可及性和可负担性的综合调查。
PLoS One. 2023 May 3;18(5):e0279817. doi: 10.1371/journal.pone.0279817. eCollection 2023.
5
Evaluation of availability, price, and affordability of cardiovascular, diabetes, and global medicines in Abuja, Nigeria.评估尼日利亚阿布贾心血管、糖尿病和全球药物的可及性、价格和可负担性。
PLoS One. 2021 Aug 12;16(8):e0255567. doi: 10.1371/journal.pone.0255567. eCollection 2021.
6
Price, availability and affordability of medicines.药品的价格、可获得性和可承受性。
Afr J Prim Health Care Fam Med. 2014 Jun 24;6(1):E1-6. doi: 10.4102/phcfm.v6i1.604.
7
Availability, pricing and affordability of selected medicines for noncommunicable diseases.某些非传染性疾病药物的供应、定价和可负担性。
East Mediterr Health J. 2019 Oct 4;25(7):473-480. doi: 10.26719/emhj.18.068.
8
Access to paediatric essential medicines: a survey of prices, availability, affordability and price components in Shaanxi Province, China.陕西省儿童基本药物的可及性:价格、供应情况、可负担性及价格构成调查
PLoS One. 2014 Mar 3;9(3):e90365. doi: 10.1371/journal.pone.0090365. eCollection 2014.
9
Availability, prices and affordability of essential medicines: A cross-sectional survey in Hanam province, Vietnam.基本药物的可及性、价格和可负担性:越南河静省的横断面调查。
PLoS One. 2021 Nov 18;16(11):e0260142. doi: 10.1371/journal.pone.0260142. eCollection 2021.
10
Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.管理心血管疾病和糖尿病的基本药物的可及性、价格和可负担性:印度喀拉拉邦的全州调查。
Trop Med Int Health. 2020 Dec;25(12):1467-1479. doi: 10.1111/tmi.13494. Epub 2020 Nov 3.

引用本文的文献

1
Assessment of prices, availability and affordability of essential medicines in Juba County, South Sudan.南苏丹朱巴县基本药物的价格、可获得性及可负担性评估。
J Pharm Policy Pract. 2023 Dec 30;16(1):172. doi: 10.1186/s40545-023-00675-5.
2
A desktop review of evaluation of implementation of national medicines policies in SADC countries.对南部非洲发展共同体(SADC)国家国家药品政策实施情况评估的桌面审查。
Heliyon. 2023 Nov 13;9(11):e22218. doi: 10.1016/j.heliyon.2023.e22218. eCollection 2023 Nov.
3
Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges.

本文引用的文献

1
Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology.使用世界卫生组织和国际卫生行动组织的方法评估孟加拉国的药品价格、可及性和可负担性。
BMC Health Serv Res. 2019 Jun 13;19(1):383. doi: 10.1186/s12913-019-4221-z.
2
Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India.评估治疗儿童癌症基本药物的可及性:印度新德里的药物可获得性、价格及可负担性研究
BMJ Glob Health. 2019 Apr 23;4(2):e001379. doi: 10.1136/bmjgh-2018-001379. eCollection 2019.
3
从药物可及性角度评估中国的罕见病国家体系:进展与挑战。
Orphanet J Rare Dis. 2022 Sep 10;17(1):352. doi: 10.1186/s13023-022-02507-2.
Medicine Prices, Availability, and Affordability in Private Health Facilities in Low-Income Settlements in Nairobi County, Kenya.
肯尼亚内罗毕县低收入住区私立医疗机构的药品价格、可及性和可负担性
Pharmacy (Basel). 2019 Apr 24;7(2):40. doi: 10.3390/pharmacy7020040.
4
A survey of availability, price and affordability of essential medicines from 2011 to 2016 in Chinese secondary and tertiary hospitals.2011 年至 2016 年中国二级和三级医院基本药物的供应、价格和可负担性调查。
Int J Equity Health. 2018 Oct 19;17(1):158. doi: 10.1186/s12939-018-0870-5.
5
Generic Medicine Pricing Policies in Europe: Current Status and Impact.欧洲仿制药定价政策:现状与影响
Pharmaceuticals (Basel). 2010 Mar 5;3(3):471-481. doi: 10.3390/ph3030471.
6
Price, availability and affordability of medicines.药品的价格、可获得性和可承受性。
Afr J Prim Health Care Fam Med. 2014 Jun 24;6(1):E1-6. doi: 10.4102/phcfm.v6i1.604.
7
The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use.八个国家实施仿制药政策的经验:促进仿制药使用成功推广的综述与建议
Saudi Pharm J. 2014 Dec;22(6):491-503. doi: 10.1016/j.jsps.2013.12.017. Epub 2013 Dec 25.
8
Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China.医改后获得平价药品的机会:来自中国西部陕西省的两项横断面调查证据。
Lancet Glob Health. 2013 Oct;1(4):e227-37. doi: 10.1016/S2214-109X(13)70072-X. Epub 2013 Sep 24.
9
Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.现状如何:评估印度计划为所有人提供免费药物时德里基本药物的价格、可及性和可负担性。
BMC Health Serv Res. 2013 Jul 25;13:285. doi: 10.1186/1472-6963-13-285.
10
Measuring medicine prices in Peru: validation of key aspects of WHO/HAI survey methodology.秘鲁药品价格测量:世卫组织/卫生技术评估和采购机构调查方法关键方面的验证。
Rev Panam Salud Publica. 2010 Apr;27(4):291-9. doi: 10.1590/s1020-49892010000400008.